Samar Hafida, MB, BCH
Obesity Medicine (Internal Medicine) Physician in Boston, Massachusetts.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 150 in Obesity Medicine (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Samar Hafida, MB, BCH filed 1,002 Medicare Part D claims in 2024 as an Obesity Medicine (Internal Medicine) Physician in Boston, Massachusetts, prescribing 20% generic.
- 1K
- Part D claims, 2024
- 20%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥75th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Samar Hafida, MB, BCH
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1952509192), first enumerated 07/10/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,002 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$49.95 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Samar Hafida, MB, BCH's individual license status. Verify directly with the state medical board.
Source: BORIM annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
Compare Hafida with other Obesity Medicine (Internal Medicine) Physician providers
Same primary specialty, same federal CMS NPPES roster.
Also enrolled in Massachusetts
- Dr. Dong Wook Kim, M.D. Boston, MA
- Dr. Jacob Moore, MD Brockton, MA
- Dr. Shirly Ramchandani, M.D. Brighton, MA
- Dr. Michael Regan, MD Norwood, MA
- Dr. Jennifer Schwartz, M.D. Fall River, MA
- Dr. Sunita Trivedi, MD Boston, MA
Other specialties in Boston: Student in an Organized Health Care Education/Training Program (7,373) · Internal Medicine Physician (3,060) · Clinical Social Worker (1,808) · Physician Assistant (1,545)
Obesity Medicine (Internal Medicine) Physician state by state →
CMS NPPES provider registry desk
NPI 1952509192 · Obesity Medicine (Internal Medicine) Physician
NPI-10 · ENUM-MID · TAX-TRACE · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1952509192
- ENUM-MID 2007
- TAX-TRACE 150
- RX-MID 1,002
- BOOK-THIN 7 in Massachusetts
- PHOTO-ENUM Jennifer Gabel, D.O. · 2007
Samar Hafida, MB, BCH's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,002 ≥ 75th percentile 75% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
Samar Hafida, MB, BCH practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Samar Hafida, MB, BCH?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Massachusetts
How Obesity Medicine (Internal Medicine) Physician compares to other specialties among Massachusetts providers
Obesity Medicine (Internal Medicine) Physician ranks #391 among Massachusetts's specialties (0% of in-state providers)
Each bar is a specialty's share of the Massachusetts provider total, by primary NUCC taxonomy. The highlighted bar is Obesity Medicine (Internal Medicine) Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Obesity Medicine (Internal Medicine) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1952509192 |
|---|---|
| Specialty | Obesity Medicine (Internal Medicine) Physician |
| Credentials | MB, BCH |
| Gender | Female |
| NPI Issued | 07/10/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Samar Hafida, MB, BCH's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1952509192 is the unique 10-digit identifier CMS uses to link Hafida across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Samar Hafida, MB, BCH bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Samar Hafida, MB, BCH. Source: openpaymentsdata.cms.gov.
Total received
$50
Largest payer
Abbott Laboratories
Most common payment type
Long term medical supply or device loan
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Massachusetts BORIM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Samar Hafida, MB, BCH. To verify Samar Hafida, MB, BCH's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
72% brand-name claims vs 20% generic, on 1,002 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 1,627.667
- Total Day Supply
- 47,349
- Brand vs Generic
- 72% brand / 20% generic
- Brand Drug Cost
- $745K
- Generic Drug Cost
- $3K
Patient Demographics
- Average Patient Age
- 64.8 years
- Avg HCC Risk Score
- 1.73
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 50, 65-74: 56, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Samar Hafida, MB, BCH prescribes most
Top Medicare Part D drugs by claim count, 2024
- Mounjaro
Mounjaro
228 claims
- Ozempic 79
Ozempic
79 claims
- Jardiance 75
Jardiance
75 claims
- Trulicity 61
Trulicity
61 claims
- Topiramate 53
Topiramate
53 claims
- Lantus Solostar 40
Lantus Solostar
40 claims
- Atorvastatin Calcium 34
Atorvastatin Calcium
34 claims
- Synjardy Xr 30
Synjardy Xr
30 claims
| Drug | Claims |
|---|---|
| Mounjaro Tirzepatide | 228 |
| Ozempic Semaglutide | 79 |
| Jardiance Empagliflozin | 75 |
| Trulicity Dulaglutide | 61 |
| Topiramate | 53 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 40 |
| Atorvastatin Calcium | 34 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 30 |
| Tresiba Flextouch U-100 Insulin Degludec | 23 |
| Metformin Hcl | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Obesity Medicine (Internal Medicine) Physician Overview
How Samar Hafida, MB, BCH fits within the Obesity Medicine (Internal Medicine) Physician landscape nationally.
Samar Hafida, MB, BCH's 1,002 claims are below the specialty average of 1,026.
Nationwide Obesity Medicine (Internal Medicine) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Hafida, both outside Massachusetts so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Frequently Asked Questions
What is Samar Hafida, MB, BCH's specialty? ▼
How much does Samar Hafida, MB, BCH prescribe under Medicare Part D? ▼
Where is Samar Hafida, MB, BCH located? ▼
What is Samar Hafida, MB, BCH's NPI number? ▼
Does Samar Hafida, MB, BCH prescribe more brand-name or generic drugs? ▼
How many Obesity Medicine (Internal Medicine) Physician providers are there in the US? ▼
What drugs does Samar Hafida, MB, BCH prescribe most often? ▼
Does Samar Hafida, MB, BCH accept Medicare? ▼
How can I verify Samar Hafida, MB, BCH's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.